Parratt JR - Search Results

1

Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.

Kaszala K, Végh A, Papp JG, Parratt JR. Kaszala K, et al. Among authors: parratt jr. Eur J Pharmacol. 1997 Jun 5;328(1):51-60. doi: 10.1016/s0014-2999(97)83027-0. Eur J Pharmacol. 1997. PMID: 9203568

2

The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity.

Babai L, Papp JG, Parratt JR, Végh A. Babai L, et al. Among authors: parratt jr. Br J Pharmacol. 2002 Jan;135(1):55-64. doi: 10.1038/sj.bjp.0704445. Br J Pharmacol. 2002. PMID: 11786480 Free PMC article.

3

Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.

Végh A, Parratt JR. Végh A, et al. Among authors: parratt jr. Cardiovasc Res. 2002 Jul;55(1):53-63. doi: 10.1016/s0008-6363(02)00342-5. Cardiovasc Res. 2002. PMID: 12062708

4

The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs.

Végh A, Parratt JR. Végh A, et al. Among authors: parratt jr. Br J Pharmacol. 2002 Dec;137(7):1107-15. doi: 10.1038/sj.bjp.0704966. Br J Pharmacol. 2002. PMID: 12429584 Free PMC article.

5

Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs.

Nagy O, Hajnal A, Parratt JR, Végh A. Nagy O, et al. Among authors: parratt jr. Br J Pharmacol. 2004 Feb;141(4):549-51. doi: 10.1038/sj.bjp.0705658. Epub 2004 Jan 26. Br J Pharmacol. 2004. PMID: 14744808 Free PMC article.

6

Delayed exercise-induced protection against arrhythmias in dogs--effect of celecoxib.

Nagy O, Hajnal A, Parratt JR, Végh A. Nagy O, et al. Among authors: parratt jr. Eur J Pharmacol. 2004 Sep 19;499(1-2):197-9. doi: 10.1016/j.ejphar.2004.07.068. Eur J Pharmacol. 2004. PMID: 15363967

7

N-2-mercaptopropionylglycine, a scavanger of reactive oxygen species, does not modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs.

Agnes H, Nagy L, Parratt JR, Papp J, Végh A. Agnes H, et al. Among authors: parratt jr. Cardiovasc Drugs Ther. 2004 Nov;18(6):449-59. doi: 10.1007/s10557-004-6222-2. Cardiovasc Drugs Ther. 2004. PMID: 15770432

8

The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning.

Vegh A, Papp JG, Szekeres L, Parratt J. Vegh A, et al. Br J Pharmacol. 1992 Dec;107(4):910-1. doi: 10.1111/j.1476-5381.1992.tb13384.x. Br J Pharmacol. 1992. PMID: 1361401 Free PMC article.

9

Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.

Vegh A, Szekeres L, Parratt J. Vegh A, et al. Br J Pharmacol. 1992 Nov;107(3):648-52. doi: 10.1111/j.1476-5381.1992.tb14501.x. Br J Pharmacol. 1992. PMID: 1472963 Free PMC article.

10

Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.

Vegh A, Papp JG, Parratt J. Vegh A, et al. Br J Pharmacol. 1994 Dec;113(4):1167-72. doi: 10.1111/j.1476-5381.1994.tb17120.x. Br J Pharmacol. 1994. PMID: 7534181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters